India Strategically Important Mkt: GSK
  • Prabha Hedge
  • Dec 16 2013

December 16: David Redfern, Chief Strategy Officer, GSK, says that the company’s decision to hike its stake in the India unit is about increasing its economic exposure in the Indian pharma business.